Advertisement


Flora E. van Leeuwen, PhD, on Hodgkin Lymphoma Treatment: Toxicities in Female Survivors

2018 Cancer Survivorship Symposium: Advancing Care and Research

Advertisement

Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute, discusses cardiovascular disease risk after treatment-induced primary ovarian insufficiency in female survivors of Hodgkin lymphoma (Abstract 114).



Related Videos

Survivorship

Paul B. Jacobsen, PhD, on The Impact of Survivorship Care Plans: Expert Perspective

Paul B. Jacobsen, PhD, of the National Cancer Institute, discusses his evaluation of whether survivorship care plans have a positive impact on health outcomes and health-care deliv...

Survivorship

Carrie R. Howell, PhD, on Reducing Risks for Childhood Cancer Survivors: Trial Results

Carrie R. Howell, PhD, of St. Jude Children’s Research Hospital, discusses study findings on a web-based exercise intervention for adolescent survivors, who are at increased risk f...

Breast Cancer
Survivorship

Electra D. Paskett, PhD, on Breast Cancer and Arm Mobility: Clinical Trial Results

Electra D. Paskett, PhD, of The Ohio State University Comprehensive Cancer Center, discusses study findings on whether exercise helps women with breast cancer regain arm mobility a...

Colorectal Cancer
Survivorship
Symptom Management

David Baraghoshi, on Colorectal Cancer and Cardiovascular Disease Risk

David Baraghoshi, of the Huntsman Cancer Institute at the University of Utah, discusses an assessment of cardiovascular risk more than 10 years after diagnosis for colorectal cance...

Survivorship

Lynda M. Beaupin, MD, on Adhering to Follow-up Care: An Analysis

Lynda M. Beaupin, MD, of the Roswell Park Cancer Institute, discusses her findings on the factors contributing to adolescent and young adult cancer survivors not seeking follow-up ...

Advertisement

Advertisement



Advertisement